Nitric oxide, oxidative stress, and progression of chronic renal failure

Seminars in Nephrology

Volumn 24, Issue 4, 2004, Pages 354-365

  Modlinger, Paul S ^a   Wilcox, Christopher S ^a,b   Aslam, Shakil ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ENDOTHELIUM DERIVED RELAXING FACTOR; MITOCHONDRIAL ENZYME; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; VASOCONSTRICTOR AGENT;

APOPTOSIS; BIOACCUMULATION; CELL DAMAGE; CHRONIC KIDNEY FAILURE; DNA DAMAGE; ENDOTHELIUM; ENZYME ACTIVITY; GLOMERULOSCLEROSIS; HUMAN; HYPERTENSION; HYPERTROPHY; KIDNEY FUNCTION; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SODIUM BALANCE; SODIUM EXCRETION; SODIUM RETENTION; VASODILATATION;

EID: 3142574854     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2004.04.007     Document Type: Article

References (106)

1. Liaudet L., Soriano F.G., Szabo C. Biology of nitric oxide signaling. Crit Care Med. 28:(suppl):2000;N37-N52
2. Murphy M.P. Nitric oxide and cell death. Biochim Biophys Acta. 1411:1999;401-414
3. Quaschning T., Krane V., Metzger T., et al. Abnormalities in uremic lipoprotein metabolism and its impact on cardiovascular disease. Am J Kidney Dis. 38:(suppl):2001;S14-S19
4. Becker B.N., Himmelfarb J., Henrich W.L., et al. Reassessing the cardiac risk profile in chronic hemodialysis patients A hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors. J Am Soc Nephrol. 8:1997;475-486
5. Zalba G., San Jose G., Moreno M.U., et al. Oxidative stress in arterial hypertension Role of NAD(P)H oxidase. Hypertension. 38:2001;1395-1399
6. Kitiyakara C., Gonin J., Massy Z., et al. Non-traditional cardiovascular disease risk factors in end-stage renal disease Oxidative stress and hyperhomocysteinemia. Curr Opin Nephrol Hypertens. 9:2001;477-487
7. Mohaupt M.G., Elzie J.L., Ahn K.Y., et al. Differential expression and induction of mRNAs encoding two inducible nitric oxide synthases in rat kidney. Kidney Int. 46:1994;653-665
8. Ujiie K., Yuen J., Hogarth L., et al. Localization and regulation of endothelial NO synthase mRNA expression in rat kidney. Am J Physiol. 267:1994;F296-F302
9. Wilcox C.S., Welch W.J., Murad F., et al. Nitric oxide synthase in macula densa regulates glomerular capillary pressure. Proc Natl Acad Sci U S A. 89:1992;11993-11997
10. Tojo A., Gross S.S., Zhang L., et al. Immunocytochemical localization of distinct isoforms of nitric oxide synthase in the juxtaglomerular apparatus of normal rat kidney. J Am Soc Nephrol. 4:1994;1438-1447
11. Welch W.J., Tojo A., Lee J.U., et al. Nitric oxide synthase in the JGA of the SHR Expression and role in tubuloglomerular feedback. Am J Physiol. 277:1999;F130-F138
12. Ahn K.Y., Mohaupt M.G., Madsen K.M., et al. In situ hybridization localization of mRNA encoding inducible nitric oxide synthase in rat kidney. Am J Physiol. 267:1994;F748-F757
13. Majid D.S.A., Navar L.G. Nitric oxide in the control of renal hemodynamics and excretory function. Am J Hypertens. 14:2001;S74-S81
14. Wilcox C.S. L-arginine-NO pathway. Seldin D.W., Giebisch G. The Kidney Physiology and Pathophysiology. 2000;849-871 Raven Press, New York
15. Ito S. Nitric oxide in the kidney. Curr Opin Nephrol Hypertens. 4:1995;28-30
16. Deng A., Baylis C. Locally produced EDRF controls preglomerular resistance and ultrafiltration coefficient. Am J Physiol. 264:1993;F212-F215
17. Baylis C., Mitruka B., Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest. 90:1992;278-281
18. Welch W.J., Wilcox C.S. What is brain nitric oxide synthase doing in the kidney? Curr Opin Nephrol Hypertens. 11:2002;109-115
19. Bramm B., Koomans H.A. Nitric oxide antagonizes the actions of angiotensin II to enhance tubuloglomerular feedback responsiveness. Kidney Int. 48:1995;1406-1411
20. Welch W.J., Wilcox C.S. Macula densa arginine delivery and uptake in the rat regulates glomerular capillary pressure Effects of salt intake. J Clin Invest. 100:1997;2235-2242
21. Gschwend S., Buikema H., Navis G., et al. Endothelial dilatory function predicts individual susceptibility to renal damage in the 5/6 nephrectomized rat. J Am Soc Nephrol. 13:2002;2909-2915
22. Ortiz P.A., Garvin J.L. Superoxide stimulates NaCl absorption by the thick ascending limb. Am J Physiol. 283:2002;F957-F962
23. Tian N., Gannon A.W., Khalil R.A., et al. Mechanisms of salt-sensitive hypertension Role of renal medullary inducible nitric oxide synthase. Am J Physiol. 284:2003;R372-R379
24. Majid D.S.A., Said K.E., Omoro S.A., et al. Nitric oxide dependency of arterial pressure-induced changes in renal interstitial hydrostatic pressure in dogs. Circ Res. 88:2001;347-351
25. Wang T. Role of iNOS and eNOS in modulating proximal tubule transport and acid-base balance. Am J Physiol. 283:2002;F658-F662
26. Wu G., Morris S.M. Jr. Arginine metabolism Nitric oxide and beyond. Biochem J. 336:1998;1-17
27. Bouby N., Hassler C., Parvy P., et al. Renal synthesis of arginine in chronic renal failure In vivo and in vitro studies in rats with 5/6 nephrectomy. Kidney Int. 44:1993;676-683
28. Vaziri N.D. Effect of chronic renal failure on nitric oxide metabolism. Am J Kidney Dis. 38:(suppl 1):2001;S74-S79
29. Vallance P., Leone A., Calver A., et al. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet. 339:1992;572-575
30. Schmidt R.J., Yokota S., Tracy T.S., et al. Nitric oxide production is low in end-stage renal disease patients on peritoneal dialysis. Am J Physiol. 276:1999;F794-F797
31. Closs E.I. Expression, regulation and function of carrier proteins for cationic amino acids. Curr Opin Nephrol Hypertens. 11:2002;99-107
32. Tojo A., Kimoto M., Wilcox C.S. Renal expression of constitutive NOS and DDAH Separate effects of salt intake and angiotensin. Kidney Int. 58:2000;2075-2083
33. Deng X., Welch W.J., Wilcox C.S. Renal vasodilation with L-arginine Effects of dietary salt. Hypertension. 26:1995;256-262
34. Kitiyakara C., Chabrashvili T., Jose P., et al. Effects of dietary salt intake on plasma arginine. Am J Physiol. 280:2001;R1069-R1075
35. Aiello S., Noris M., Todeschini M., et al. Renal and systemic nitric oxide synthesis in rats with renal mass reduction. Kidney Int. 52:1997;171-181
36. Aiello S., Noris M., Remuzzi G. Nitric oxide/L-arginine in uremia. Miner Electrolyte Metab. 25:1999;384-390
37. Vaziri N.D., Ni Z., Wang X.Q., et al. Downregulation of nitric oxide synthase in chronic renal insufficiency Role of excess PTH. Am J Physiol. 274:1998;F642-F649
38. Panza J.A., Garcia C.E., Kilcoyne C.M., et al. Impaired endothelium-dependent vasodilation in patients with essential hypertension. Circulation. 91:1995;1732-1738
39. 1 receptor antagonist combats oxidative stress and restores nitric oxide signaling in the SHR. Kidney Int. 59:2001;1257-1263
40. Welch W.J., Tojo A., Wilcox C.S. Roles of NO and oxygen radicals in tubuloglomerular feedback in SHR. Am J Physiol. 278:2000;F769-F776
41. Blum M., Yachnin T., Wollman Y., et al. Low nitric oxide production in patients with chronic renal failure. Nephron. 79:1998;265-268
42. Schmidt R.J., Domico J., Samsell L.S., et al. Indices of activity of the nitric oxide system in hemodialysis patients. Am J Kidney Dis. 34:1999;228-234
43. Schmidt R.J., Baylis C. Total nitric oxide production is low in patients with chronic renal disease. Kidney Int. 58:2000;1261-1266
44. Xiao S., Wagner L., Schmidt R.J., et al. Circulating endothelial nitric oxide synthase inhibitory factor in some patients with chronic renal disease. Kidney Int. 59:2001;1466-1472
45. Xiao S., Wagner L., Mahaney J., et al. Uremic levels of urea inhibit L-arginine transport in cultured endothelial cells. Am J Physiol. 280:2001;F989-F995
46. Wever R., Boer P., Hijmering M., et al. Nitric oxide production is reduced in patients with chronic renal failure. Arterioscler Thromb Vasc Biol. 19:1999;1168-1172
47. Forte P., Copland M., Smith L.M., et al. Basal nitric oxide synthesis in essential hypertension. Lancet. 349:1997;837-842
48. Wang D., Iversen J., Strandgaard S. Endothelium-dependent relaxation of small resistance vessels is impaired in patients with autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 11:2000;1371-1376
49. Cross J.M., Donald A.E., Kharbanda R., et al. Acute administration of L-arginine does not improve arterial endothelial function in chronic renal failure. Kidney Int. 60:2001;2318-2323
50. Wilcox C.S. Reactive oxygen species Role in blood pressure and kidney function. Curr Hypertens Rep. 4:2002;160-166
51. phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res. 87:2000;26-32
52. phox homologues in vascular smooth muscle cells Nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res. 88:2001;888-894
53. Zou A.P., Li N., Cowley A.W. Production and actions of superoxide in the renal medulla. Hypertension. 37:2001;547-553
54. Makino A., Skelton M.M., Zou A.P., et al. Increased renal medullary oxidative stress produces hypertension. Hypertension. 39:2002;667-672
55. Li N., Yi F.X., Spurrier J.L., et al. Production of superoxide through NADH oxidase in thick ascending limb of Henle's loop in rat kidney. Am J Physiol. 282:2002;F1111-F1119
56. Chabrashvili T., Tojo A., Onozato M.L., et al. Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension. 39:2002;269-274
57. Zalba G., Beaumont F.J., San Jose G., et al. Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats. Hypertension. 35:2000;1055-1061
58. Kawada N., Imai E., Karber A., et al. A mouse model of angiotensin II slow pressor response Role of oxidative stress. J Am Soc Nephrol. 13:2002;2860-2868
59. phox in aortas from angiotensin II-infused mice. Am J Physiol. 279:2000;H2234-H2240
60. Chabrashvili T., Kitiyakara C., Blau J., et al. Effects of Ang II type 1 and type 2 receptors on oxidative stress and renal NADPH oxidase and SODs expression. Am J Physiol. 285:2003;R117-R124
61. Lenda D.M., Boegehold M.A. Effect of a high-salt diet on oxidant enzyme activity in skeletal muscle microcirculation. Am J Physiol. 282:2002;H395-H402
62. Beswick R.A., Dorrance A.M., Leite R., et al. NADH/NADPH oxidase and enchanced superoxide production in the mineralocorticoid hypertensive rat. Hypertension. 38:2001;1107-1111
63. Fleming I. Cytochrome p450 and vascular homeostasis. Circ Res. 89:2001;753-762
64. Schnackenberg C.G. Physiological and pathophysiological roles of oxygen radical in the renal microvasculature. Am J Physiol. 282:2002;R335-R342
65. Schnackenberg C.G., Welch W.J., Wilcox C.S. Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic Role of nitric oxide. Hypertension. 32:1998;59-64
66. Majid D.S.A., Nishiyama A. Nitric oxide blockade enhances renal responses to superoxide dismutase inhibition in dogs. Hypertension. 39:2002;293-297
67. Zhou X.J., Vaziri N.D., Wang X.Q., et al. Nitric oxide synthase expression in hypertension induced by inhibition of glutathione synthase. J Pharmacol Exp Ther. 300:2002;762-767
68. Vaziri N.D., Wang X.Q., Oveisi F., et al. Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats. Hypertension. 36:2000;142-146
69. Ganafa A.A., Socci R.R., Eatman D., et al. Acute inhibition of glutathione biosynthesis alters endothelial function and blood pressure in rats. Eur J Pharmacol. 454:2002;217-223
70. Vaziri N.D., Ni Z., Oveisi F., et al. Enhanced nitric oxide inactivation and protein nitration by reactive oxygen species in renal insufficiency. Hypertension. 39:2002;135-141
71. Vaziri N.D., Dicus M., Ho N.D., et al. Oxidative stress and dysregulation of superoxide dismutase and NADPH oxidase in renal insufficiency. Kidney Int. 63:2003;179-185
72. Hasdan G., Benchetrit S., Rashid G., et al. Endothelial dysfunction and hypertension in 5/6 nephrectomized rats are mediated by vascular superoxide. Kidney Int. 61:2002;586-590
73. Gaertner S.A., Janssen U., Ostendorf T., et al. Glomerular oxidative and antioxidative systems in experimental mesangioproliferative glomerulonephritis. J Am Soc Nephrol. 13:2002;2930-2937
74. Annuk M., Lind L., Linde T., et al. Impaired endothelium-dependent vasodilatation in renal failure in humans. Nephrol Dial Transplant. 16:2001;302-306
75. van Guldener C., Janssen M.J., Lambert J., et al. Endothelium-dependent vasodilatation is impaired in peritoneal dialysis patients. Nephrol Dial Transplant. 13:1998;1782-1786
76. Kari J.A., Donald A.E., Vallance D.T., et al. Physiology and biochemistry of endothelial function in children with chronic renal failure. Kidney Int. 52:1997;468-472
77. Annuk M., Zilmer M., Lind L., et al. Oxidative stress and endothelial function in chronic renal failure. J Am Soc Nephrol. 12:2001;2747
78. Handelman G.J., Walter M.F., Adhikarla R., et al. Elevated plasma F2-isoprostanes in patients on long-term hemodialysis. Kidney Int. 59:2001;1960-1966
79. Clermont G., Lecour S., Lahet J., et al. Alteration in plasma antioxidant capacities in chronic renal failure and hemodialysis patients A possible explanation for the increased cardiovascular risk in these patients. Cardiovasc Res. 47:2000;618-623
80. Ikizler TA, Morrow JD, Roberts LJ, et al. Plasma F2- isoprostane levels are elevated in chronic hemodialysis patients. Clin Nephrol 58:190-197, 20032
81. Mimic-Oka J., Simic T., Djukanovic L., et al. Alteration in plasma antioxidant capacity in various degrees of chronic renal failure. Clin Nephrol. 51:1999;233-241
82. Himmelfarb J., Stenvinkel P., Ikizler T.A., et al. The elephant in uremia Oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int. 62:2002;1524-1538
83. Erdogan C., Unlucerci Y., Turkmen A., et al. The evaluation of oxidative stress in patients with chronic renal failure. Clin Chim Acta. 322:2002;157-161
84. Heidland A., Sebekova K., Schinzel R. Advanced glycation end products and the progressive course of renal disease. Am J Kidney Dis. 38:(suppl 1):2001;S100-S106
85. Raj D.S.C., Choudhury D., Welbourne T.C., et al. Advanced glycation end products A nephrologist's perspective. Am J Kidney Dis. 35:2000;365-380
86. Attia D.M., Vergagen A.M., Stroes E.S., et al. Vitamin E alleviates renal injury, but not hypertension, during chronic nitric oxide synthase inhibition in rats. J Am Soc Nephrol. 12:2001;2585-2593
87. Stulak J.M., Lerman A., Porcel M.R., et al. Renal vascular function in hypercholesterolemia is preserved by chronic antioxidant supplementation. J Am Soc Nephrol. 12:2001;1882-1891
88. Ganafa A.A., Socci R.R., Eatman D., et al. Effect of palm oil on oxidative stress-induced hypertension in Sprague-Dawley rats. Am J Hypertens. 15:2002;725-731
89. De Caterina R., Cipollone F., Filard F.P., et al. Low-density lipoprotein level reduction by the 3-hydroxy-3-methylglutaryl coenzyme-A inhibitor simvastatin is accompanied by a related reduction of F2-isoprostane formation in hypercholesterolemic subjects No further effect of vitamin E. Circulation. 106:2002;2543-2549
90. Waddington S., Cook H.T., Reaveley D., et al. L-arginine depletion inhibits glomerular nitric oxide synthesis and exacerbates rat nephrotoxic nephritis. Kidney Int. 49:1996;1090-1096
91. Ashab I., Peer G., Blum M., et al. Oral administration of L-arginine and captopril in rats prevents chronic renal failure by nitric oxide production. Kidney Int. 47:1995;1515-1521
92. Katoh T., Takahashi K., Klahr S., et al. Dietary supplementation with L-arginine ameliorates glomerular hypertension in rats with subtotal nephrectomy. J Am Soc Nephrol. 4:1994;1690-1694
93. Reyes A.A., Karl I.E., Kissane J., et al. L-arginine administration prevents glomerular hyperfiltration and decreases proteinuria in diabetic rats. J Am Soc Nephrol. 4:1993;1039-1045
94. Bennett-Richards K.J., Kattenhorn M., Donald A.E., et al. Oral L-arginine does not improve endothelial dysfunction in children with chronic renal failure. Kidney Int. 62:2002;1372-1378
95. Deng G., Vaziri N.D., Jabbari B., et al. Increased tyrosine nitration of the brain in chronic renal insufficiency Reversal by antioxidant therapy and angiotensin-converting enzyme inhibition. J Am Soc Nephrol. 12:2001;1892-1899
96. Onozato M.L., Tojo A., Goto A., et al. Oxidative stress and nitric oxide synthase in rat diabetic nephropathy Effects of ACEI or ARB. Kidney Int. 61:2002;186-194
97. de Gasparo M., Hess P., Clozel M., et al. Combination of low-dose valsartan and enalapril improves endothelial dysfunction and coronary reserve in Nomega-nitro-L-arginine methyl ester-treated spontaneously hypertensive rats. J Cardiovasc Pharmacol. 40:2002;789-800
98. Ward R.A., Ouseph R., McLeish K.R. Effects of high-flux hemodialysis on oxidant stress. Kidney Int. 63:2003;353-359
99. Tarng D.C., Huang T.P., Liu T.Y., et al. Effect of vitamin E-bonded membrane on the 8-hydroxy 2′-deoxyguanosine level in leukocyte DNA of hemodialysis patients. Kidney Int. 58:2000;790-799
100. Tarng D.C., Wei Y.H., Huang T.P., et al. Intravenous ascorbic acid as an adjuvant therapy for recombinant erythropoietin in hemodialysis patients with hyperferritinemia. Kidney Int. 55:1999;2477-2486
101. Mune M., Yukawa S., Kishino M., et al. Effect of vitamin E on lipid metabolism and atherosclerosis in ESRD patients. Kidney Int. 56:1999;S126-S129
102. Tsuruoka S., Kawaguchi A.T., Nishiki K., et al. Vitamin E-bonded hemodialyzer improves neutrophil function and oxidative stress in patients with end-stage renal failure. Am J Kidney Dis. 39:2002;127-133
103. Clermont G., Lecour S., Cabanne J.F., et al. Vitamin E-coated dialyzer reduces oxidative stress in hemodialysis patients. Free Radic Biol Med. 31:2001;233-241
104. Arosio E., De Marchi S., Zannoni M., et al. Effect of glutathione infusion on leg arterial circulation, cutaneous microcirculation, and pain-free walking distance in patients with peripheral obstructive arterial disease A randomized, double-blind, placebo-controlled trial. Mayo Clin Proc. 77:2002;754-759
105. Boaz M., Smetana S., Weinstein T., et al. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE) Randomised placebo-controlled trial. Lancet. 356:2000;1213-1218
106. Robert C.K., Vaziri N.D., Barnard R.J. Effect of diet and exercise intervention on blood pressure, insulin, oxidative stress, and nitric oxide availability. Circulation. 106:2002;2530-2532